Key result
In rat brain capillary endothelial cells, 2-MeSADP strongly inhibited forskolin-stimulated adenylyl cyclase (EC50 2.2 nM), indicating the presence of a P2Y(T)-type receptor.
Effect estimate: EC50 2.2 nM
Rat brain capillary endothelial cells possess a P2YT-type receptor that is coupled to the inhibition of adenylyl cyclase, distinct from the P2Y1 receptor.
Rat brain capillaries express distinct P2Y(T) receptor; extends rodent purinergic data but leaves open human cerebrovascular relevance.
A P2Y (nucleotide) receptor activity in a clonal population (B10) of rat brain capillary endothelial cells is coupled to inhibition of adenylyl cyclase and has functional similarities to the P2Y(T) (previously designated 'P2T') receptor for ADP of blood platelets. However, the only P2Y receptor which was detectable in a previous study of B10 cells by mRNA analysis was the P2Y(1) receptor, which elsewhere shows no transduction via cyclic nucleotides. We have sought here to clarify these issues. 2. The inhibition of forskolin-stimulated adenylyl cyclase induced by purified nucleotides was measured on B10 cells. The EC(50) value for 2-methylthioADP (2-MeSADP) was 2.2 nM and, surprisingly, 2-MeSATP was an almost equally strong agonist (EC(50)=3.5 nM). ATP and 2-ClATP were weak partial agonists (EC(50)=26 microM and 10 microM respectively) and under appropriate conditions could antagonise the activity on 2-MeSADP. 3. A known selective antagonist of the platelet P2Y(T) receptor, 2-propylthioadenosine-5'-(beta,gamma)-difluoromethylene) triphosphonate (AR-C 66096), was a competitive antagonist of this B10 cell receptor, with pK(B)=7.6. That ligand is inactive at the P2Y(1) receptor in the same cells. Conversely, the competitive P2Y(1) receptor antagonists, the 3', 5'- and 2', 5'-adenosine bis-monophosphates, are, instead, weak agonists at the adenylyl cyclase-inhibitory receptor. 4. The inhibition of adenylyl cyclase by 2-MeSADP was completely abolished by pertussis toxin. 5. In summary, these brain endothelial cells possess a P2Y(T)-type receptor in addition to the P2Y(1) receptor. The two have similarities in agonist profiles but are clearly distinguishable by antagonists and by their second messenger activations. The possible relationships between the B10 and platelet P2Y(T) receptors are discussed.
No takes yet. Share an insight, caveat, or question.
Simon et al. (2001) studied this question. 2-methylthioADP (2-MeSADP) was evaluated on Inhibition of forskolin-stimulated adenylyl cyclase (EC50 2.2 nM). In rat brain capillary endothelial cells, 2-MeSADP strongly inhibited forskolin-stimulated adenylyl cyclase (EC50 2.2 nM), indicating the presence of a P2Y(T)-type receptor.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: